Horizon Discovery Launches Companion Dx Subsidiary

The new venture, Horizon Dx, will use its parent company's isogenic cell model technology to help develop companion diagnostics, initially in the area of cancer.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.